SION — SIONNA THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About SIONNA THERAPEUTICS INC (SION)
SIONNA THERAPEUTICS INC (SION) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Andreas Halvorsen (Viking Global Investors), valued at $131M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in SION
How many top investors track SION
A small number of top investors own this.
SION Ownership Composition
How SIONNA THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Other97.1%
- Hedge Funds2.9%
Tracked investors reporting SION
- Andreas HalvorsenMar 31, 2026Viking Global InvestorsShares3.2MValue$128.1M% Portfolio0.36%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares1.2MValue$46.8M% Portfolio0.01%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares140.6KValue$5.6M% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares136.5KValue$5.5M% Portfolio0.01%
Recent activity
- $131.4MFeb 17, 2026
- $128.1MMay 15, 2026
Frequently asked questions
- How many institutional investors hold SION?
- 4 tracked institutional investors disclosed a position in SION (SIONNA THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of SION?
- Andreas Halvorsen, Viking Global Investors, holds the largest disclosed position in SION, valued at $131M.
- Did institutional ownership of SION increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited SION.
- Where does this SION ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.